{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Blinded+%28placebo%29&page=69", "query": { "intervention": "Blinded (placebo)", "page": 69 }, "page_size": 10 }, "pagination": { "page": 69, "page_size": 10, "total_count": 2214, "total_pages": 222, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Blinded+%28placebo%29&page=70&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Blinded+%28placebo%29&page=68&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-24T22:46:16.882Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03995108", "title": "Efficacy and Safety Study of Mavorixafor in Participants With Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "WHIM Syndrome" ], "interventions": [ { "name": "Mavorixafor", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "X4 Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 31, "start_date": "2019-10-24", "completion_date": "2025-12-23", "has_results": false, "last_update_posted_date": "2026-07-06", "last_synced_at": "2026-10-24T22:46:16.882Z", "location_count": 6, "location_summary": "San Diego, California • Thousand Oaks, California • Iowa City, Iowa + 3 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Thousand Oaks", "state": "California" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03995108" }, { "nct_id": "NCT04473690", "title": "KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Covid19" ], "interventions": [ { "name": "Low Dose of KBP-COVID-19", "type": "BIOLOGICAL" }, { "name": "High Dose of KBP-COVID-19", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "KBio Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 102, "start_date": "2020-12-30", "completion_date": "2022-10-14", "has_results": true, "last_update_posted_date": "2025-05-18", "last_synced_at": "2026-10-24T22:46:16.882Z", "location_count": 6, "location_summary": "West Palm Beach, Florida • Meridian, Idaho • Winston-Salem, North Carolina + 3 more", "locations": [ { "city": "West Palm Beach", "state": "Florida" }, { "city": "Meridian", "state": "Idaho" }, { "city": "Winston-Salem", "state": "North Carolina" }, { "city": "Brownsville", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04473690" }, { "nct_id": "NCT00588406", "title": "Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Budesonide", "type": "DRUG" }, { "name": "albuterol", "type": "DRUG" }, { "name": "Ipratropium bromide", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Northwell Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 95, "start_date": "2007-09", "completion_date": "2009-12", "has_results": true, "last_update_posted_date": "2016-01-21", "last_synced_at": "2026-10-24T22:46:16.882Z", "location_count": 3, "location_summary": "East Meadow, New York • Queens, New York • The Bronx, New York", "locations": [ { "city": "East Meadow", "state": "New York" }, { "city": "Queens", "state": "New York" }, { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00588406" }, { "nct_id": "NCT00725803", "title": "Evaluation of the Safety, Tolerability, Pharmacokinetics, and Activity of GS-9450 in Subjects With Chronic HCV", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "HCV Infection" ], "interventions": [ { "name": "GS-9450", "type": "DRUG" }, { "name": "GS-9450 Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 33, "start_date": "2008-04", "completion_date": "2009-03", "has_results": false, "last_update_posted_date": "2014-06-19", "last_synced_at": "2026-10-24T22:46:16.882Z", "location_count": 5, "location_summary": "Anaheim, California • Washington D.C., District of Columbia • Orlando, Florida + 2 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Orlando", "state": "Florida" }, { "city": "Dallas", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00725803" }, { "nct_id": "NCT01410227", "title": "Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Von Willebrand Disease" ], "interventions": [ { "name": "Recombinant von Willebrand factor (rVWF)", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Recombinant factor VIIII (rFVIII)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Baxalta now part of Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 49, "start_date": "2011-11-01", "completion_date": "2014-02-01", "has_results": true, "last_update_posted_date": "2021-05-19", "last_synced_at": "2026-10-24T22:46:16.882Z", "location_count": 10, "location_summary": "Sacramento, California • Miami, Florida • Peoria, Illinois + 7 more", "locations": [ { "city": "Sacramento", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Peoria", "state": "Illinois" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Newark", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01410227" }, { "nct_id": "NCT02004691", "title": "Efficacy, Safety, Pharmacodynamic, and Pharmacokinetics Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Sphingomyelin Lipidosis" ], "interventions": [ { "name": "placebo (saline)", "type": "DRUG" }, { "name": "Olipudase alfa", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Genzyme, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "2015-12-18", "completion_date": "2023-10-19", "has_results": true, "last_update_posted_date": "2024-11-07", "last_synced_at": "2026-10-24T22:46:16.882Z", "location_count": 3, "location_summary": "San Francisco, California • Decatur, Georgia • The Bronx, New York", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Decatur", "state": "Georgia" }, { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02004691" }, { "nct_id": "NCT07304024", "title": "A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Central Auditory Processing Disorder", "Hearing Impaired (Partially)", "Hearing", "Hearing Abnormality", "Hearing Disability", "Hearing Disorder", "Hearing Disorders", "Hearing Impairment, Sensorineural", "Hearing Handicap", "Hearing Impaired", "Hearing Impairment", "Hearing Loss", "Central Auditory Disease", "Noise Exposure", "Noise Induced Hearing Loss", "Noise-Induced Hearing Loss", "Sound Perception", "Myelin Degeneration", "Myelinopathy", "Myelin Integrity", "Remyelination", "Hidden Hearing Loss", "Cocktail Party Skill", "Cocktail Party Syndrome", "CAPD", "Age Problem" ], "interventions": [ { "name": "Clemastine Fumarate Combined With Engineered Sound", "type": "COMBINATION_PRODUCT" }, { "name": "Clemastine Fumarate Combined With Pink Noise", "type": "DRUG" }, { "name": "Placebo Drug With Engineered Sound", "type": "COMBINATION_PRODUCT" }, { "name": "Placebo - Placebo", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT", "DRUG" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "45 Years to 65 Years" }, "enrollment_count": 344, "start_date": "2025-03-31", "completion_date": "2028-07", "has_results": false, "last_update_posted_date": "2026-04-30", "last_synced_at": "2026-10-24T22:46:16.882Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT07304024" }, { "nct_id": "NCT07322146", "title": "Trial of Reducing Inpatient Antibiotic Durations in Children", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pneumonia", "Skin and Soft Tissue (SST) Infection", "Urinary Tract Infections (UTIs)" ], "interventions": [ { "name": "Study Drug Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Days", "maximum_age": "17 Years", "sex": "ALL", "summary": "60 Days to 17 Years" }, "enrollment_count": 1200, "start_date": "2026-02-13", "completion_date": "2031-08", "has_results": false, "last_update_posted_date": "2026-04-29", "last_synced_at": "2026-10-24T22:46:16.882Z", "location_count": 10, "location_summary": "Birmingham, Alabama • Aurora, Colorado • Washington D.C., District of Columbia + 6 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT07322146" }, { "nct_id": "NCT07137988", "title": "Effect of Acute Grape Seed Extract Supplementation on the Heart Rate Recovery in Young Individuals", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Healthy Young Men" ], "interventions": [ { "name": "600 mg grape seed extract", "type": "DIETARY_SUPPLEMENT" }, { "name": "600 mg Starch", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "California Baptist University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "30 Years", "sex": "MALE", "summary": "18 Years to 30 Years · Male only" }, "enrollment_count": 12, "start_date": "2024-10-03", "completion_date": "2024-12-31", "has_results": false, "last_update_posted_date": "2025-08-22", "last_synced_at": "2026-10-24T22:46:16.882Z", "location_count": 1, "location_summary": "Riverside, California", "locations": [ { "city": "Riverside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07137988" }, { "nct_id": "NCT00233935", "title": "Defined Green Tea Catechin Extract in Preventing Esophageal Cancer in Patients With Barrett's Esophagus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Barrett Esophagus" ], "interventions": [ { "name": "placebo", "type": "OTHER" }, { "name": "defined green tea catechin extract", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 55, "start_date": "2005-11", "completion_date": "2010-11", "has_results": false, "last_update_posted_date": "2014-09-11", "last_synced_at": "2026-10-24T22:46:16.882Z", "location_count": 3, "location_summary": "New York, New York • Houston, Texas", "locations": [ { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00233935" } ] }